venBio Partners LLC
Annual return '25
+22.9%
SPY '25
+17.7%
Alpha
+5.2ptsvs SPY
Invested
$280.6M
Holdings
6
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 100%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$PHVS
PHARVARIS N V
Q4 2025: Exited (was 4.64M shares)
46.7%
02
$ALMS
ALUMIS INC
Q4 2025: Exited (was 4.62M shares)
35.6%
03
$ALXO
ALX ONCOLOGY HLDGS INC
Q4 2025: Exited (was 9.70M shares)
9.2%
04
$HRMY
HARMONY BIOSCIENCES HLDGS IN
Q4 2025: Exited (was 489.2k shares)
4.9%
05
$LYEL
LYELL IMMUNOPHARMA INC
Q4 2025: Exited (was 473.5k shares)
2.4%
06
$ARTV
ARTIVA BIOTHERAPEUTICS INC
Q4 2025: Exited (was 1.15M shares)
1.2%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 10:33 UTC.